JIA clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
The proposed study is a stratified, block-randomized, double-masked, controlled trial to determine the feasibility of discontinuing adalimumab treatment in patients with quiescent uveitis associated with juvenile idiopathic arthritis (JIA).
San Francisco, California and other locations